Literature DB >> 21310725

Independent contribution of temporal beta-amyloid deposition to memory decline in the pre-dementia phase of Alzheimer's disease.

Gaël Chételat1, Victor L Villemagne, Kerryn E Pike, Kathryn A Ellis, Pierrick Bourgeat, Gareth Jones, Graeme J O'Keefe, Olivier Salvado, Cassandra Szoeke, Ralph N Martins, David Ames, Colin L Masters, Christopher C Rowe.   

Abstract

The relationship between β-amyloid deposition and memory deficits in early Alzheimer's disease is unresolved, as past studies show conflicting findings. The present study aims to determine the relative contribution of regional β-amyloid deposition, hippocampal atrophy and white matter integrity to episodic memory deficits in non-demented older individuals harbouring one of the characteristic hallmarks of Alzheimer's disease, i.e. with β-amyloid pathology. Understanding these relationships is critical for effective therapeutic development. Brain magnetic resonance imaging and [(11)C]Pittsburgh Compound B-positron emission tomography scans were obtained in 136 non-demented individuals aged over 60 years, including 93 healthy elderly and 43 patients with mild cognitive impairment. Voxel-based correlations were computed between a memory composite score and grey matter volume, white matter volume and β-amyloid deposition imaging datasets. Hierarchical linear regression analyses were then performed using values extracted in regions of most significant correlations to determine the relative contribution of each modality to memory deficits. All analyses were conducted pooling all groups together as well as within separate subgroups of cognitively normal elderly, patients with mild cognitive impairment and individuals with high versus low neocortical β-amyloid. Brain areas of highest correlation with episodic memory deficits were the hippocampi for grey matter volume, the perforant path for white matter volume and the temporal neocortex for β-amyloid deposition. When considering these three variables together, only hippocampal volume and temporal β-amyloid deposition provided independent contributions to memory deficits. In contrast to global β-amyloid deposition, temporal β-amyloid deposition was still related to memory independently from hippocampal atrophy within subgroups of cognitively normal elderly, patients with mild cognitive impairment or cases with high neocortical β-amyloid. In the pre-dementia stage of Alzheimer's disease, subtle episodic memory impairment is related to β-amyloid deposition, especially in the temporal neocortex, and independently from hippocampal atrophy, suggesting that both factors should be independently targeted in therapeutic trials aimed at reducing cognitive decline.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21310725     DOI: 10.1093/brain/awq383

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  48 in total

1.  Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.

Authors:  Reisa A Sperling; Paul S Aisen; Laurel A Beckett; David A Bennett; Suzanne Craft; Anne M Fagan; Takeshi Iwatsubo; Clifford R Jack; Jeffrey Kaye; Thomas J Montine; Denise C Park; Eric M Reiman; Christopher C Rowe; Eric Siemers; Yaakov Stern; Kristine Yaffe; Maria C Carrillo; Bill Thies; Marcelle Morrison-Bogorad; Molly V Wagster; Creighton H Phelps
Journal:  Alzheimers Dement       Date:  2011-04-21       Impact factor: 21.566

2.  Cerebrovascular disease, β-amyloid, and cognition in aging.

Authors:  Natalie L Marchant; Bruce R Reed; Charles S DeCarli; Cindee M Madison; Michael W Weiner; Helena C Chui; William J Jagust
Journal:  Neurobiol Aging       Date:  2011-11-01       Impact factor: 4.673

Review 3.  Understanding cognitive deficits in Alzheimer's disease based on neuroimaging findings.

Authors:  Meredith N Braskie; Paul M Thompson
Journal:  Trends Cogn Sci       Date:  2013-09-09       Impact factor: 20.229

4.  Vascular risk and FDDNP-PET influence cognitive performance.

Authors:  David A Merrill; Prabha Siddarth; Vladimir Kepe; Pushpa V Raja; Nathan Saito; Linda M Ercoli; Karen J Miller; Helen Lavretsky; Susan Y Bookheimer; Jorge R Barrio; Gary W Small
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

5.  Association of gray matter atrophy with age, β-amyloid, and cognition in aging.

Authors:  Hwamee Oh; Cindee Madison; Sylvia Villeneuve; Candace Markley; William J Jagust
Journal:  Cereb Cortex       Date:  2013-02-06       Impact factor: 5.357

6.  Aβ-related hyperactivation in frontoparietal control regions in cognitively normal elderly.

Authors:  Hwamee Oh; Jason Steffener; Qolamreza R Razlighi; Christian Habeck; Dan Liu; Yunglin Gazes; Sarah Janicki; Yaakov Stern
Journal:  Neurobiol Aging       Date:  2015-08-24       Impact factor: 4.673

Review 7.  Emerging biomarkers in cognition.

Authors:  Meredith Wicklund; Ronald C Petersen
Journal:  Clin Geriatr Med       Date:  2013-11       Impact factor: 3.076

8.  Fibrillar amyloid correlates of preclinical cognitive decline.

Authors:  Cynthia M Stonnington; Kewei Chen; Wendy Lee; Dona E C Locke; Amylou C Dueck; Xiaofen Liu; Auttawut Roontiva; Adam S Fleisher; Richard J Caselli; Eric M Reiman
Journal:  Alzheimers Dement       Date:  2013-04-11       Impact factor: 21.566

9.  Voxel-based Morphometry of Brain MRI in Normal Aging and Alzheimer's Disease.

Authors:  Hiroshi Matsuda
Journal:  Aging Dis       Date:  2012-12-04       Impact factor: 6.745

Review 10.  Is amyloid-β harmful to the brain? Insights from human imaging studies.

Authors:  William Jagust
Journal:  Brain       Date:  2015-11-27       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.